Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target-specific second-line therapy of metastatic urothelial carcinoma with temsirolimus
2008-008478-30Phase 2Active
- Sponsor
- Lukas Krankenhaus Neuss
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in transitional cell carcinoma (TCC), sponsored by Lukas Krankenhaus Neuss. Primary endpoint: overall survival. Started Jan 2009; status: active.
02
Drugs
temsirolimus
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2008-008478-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008478-30.